Agenus Company Profile (NASDAQ:AGEN)

About Agenus

Agenus Inc. (Agenus) is an immuno-oncology company. The Company is engaged in discovering and developing treatments for patients with cancer. Its approaches are driven by platforms and programs, which include antibody discovery platform, including Retrocyte Display, SECANT yeast display and phage display technologies designed to produce human antibodies; antibody candidate programs, including checkpoint modulator (CPM) programs; vaccine programs, including Prophage and AutoSynVax, and saponin-based vaccine adjuvants, principally QS-21 Stimulon adjuvant (QS-21 Stimulon). The Company has a portfolio of programs in various stages of development, including a series of antibodies in discovery and pre-clinical and clinical development, Prophage vaccine, a Heat Shock Protein (HSP)-based vaccine candidate for a form of brain cancer that has completed Phase II trials, and a number of QS-21 Stimulon-containing vaccine candidates in late stage development.

Industry, Sector and Symbol:

• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Exchange: NASDAQ
• Symbol: AGEN
• CUSIP: 00847G70

Key Metrics:

• Previous Close: $7.00
• 50 Day Moving Average: $6.31
• 200 Day Moving Average: $4.71
• 52-Week Range: $2.61 - $7.30
• Trailing P/E Ratio: N/A
• Foreward P/E Ratio: -5.61
• P/E Growth: 0.00
• Market Cap: $599.69M
• Outstanding Shares: 86,912,000
• Beta: 2.02

Profitability:

• Net Margins: -328.53%
• Return on Equity: -138.27%
• Return on Assets: -32.03%

Debt:

• Debt-to-Equity Ratio: 7.24%
• Current Ratio: 4.12%
• Quick Ratio: 4.11%

Additional Links:

• Visit Agenus' Official Website
• View AGEN on Google Finance
• View AGEN on Yahoo Finance
• View AGEN's Company Profile on Reuters
• Search for Agenus Inc. on Google

Companies Related to Agenus:

• Abaxis (NASDAQ:ABAX)
• Emergent Biosolutions (NYSE:EBS)
• Community Health Systems (NYSE:CYH)
• Achillion Pharmaceuticals (NASDAQ:ACHN)
• Conmed Corp. (NASDAQ:CNMD)
• Aerie Pharmaceuticals (NASDAQ:AERI)
• Lannett (NYSE:LCI)
• Repligen Corp. (NASDAQ:RGEN)
• Amicus Therapeutics (NASDAQ:FOLD)
• Phibro Animal Health Corp. (NASDAQ:PAHC)

Earnings

Earnings History for Agenus (NASDAQ:AGEN)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call	Details
10/25/2016
7/28/2016	Q216	($0.34)	($0.33)	$5.12 million	$6.59 million	View	Listen
4/28/2016	Q116	($0.23)	($0.37)	$5.16 million		View	Listen
3/3/2016	Q415	($0.17)	($0.18)	$9.39 million	$7.64 million	View	Listen
10/27/2015	Q315	($0.15)	($0.16)	$7.56 million		View	Listen
7/23/2015	Q215	($0.15)	($0.44)	$5.71 million	$6.38 million	View	Listen
4/23/2015	Q115	($0.01)	($0.28)	$11.66 million	$3.95 million	View	N/A
2/26/2015	Q414	($0.16)	($0.41)		$1.62 million	View	N/A
10/31/2014	Q314	($0.15)	($0.13)	$1.96 million	$1.56 million	View	N/A
7/24/2014	Q214	($0.17)	($0.12)		$3.07 million	View	N/A
5/8/2014	Q114	($0.13)	($0.01)	$0.55 million	$0.72 million	View	N/A
3/5/2014	Q413	($0.24)	($0.16)	$870.00 million	$393.00 million	View	N/A
10/24/2013	Q313	($0.27)	($0.24)		$736.00 million	View	N/A
7/25/2013	Q2 2013	($0.21)	($0.40)			View	N/A
2/28/2013	Q4 2012	($0.24)	($0.23)	$0.72 million	$1.09 million	View	N/A
7/28/2011		($0.05)	($0.05)			View	N/A

(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Agenus (NASDAQ:AGEN)

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	1	($0.18)	($0.18)	($0.18)
Q2 2016	1	($0.39)	($0.39)	($0.39)
Q3 2016	1	($0.44)	($0.44)	($0.44)
Q4 2016	1	($0.47)	($0.47)	($0.47)
Q1 2017	1	($0.24)	($0.24)	($0.24)
Q2 2017	1	($0.24)	($0.24)	($0.24)
Q3 2017	1	($0.25)	($0.25)	($0.25)
Q4 2017	1	($0.25)	($0.25)	($0.25)

(Data provided by Zacks Investment Research)

Dividends

Dividend History for Agenus (NASDAQ:AGEN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Agenus (NASDAQ:AGEN)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Details
9/6/2016	Ulf Wiinberg	Director	Buy	30,000	$6.29	$188,700.00
5/9/2016	Garo H Armen	CEO	Buy	100,000	$3.18	$318,000.00
5/5/2016	Ozer Baysal	Insider	Buy	2,250	$3.10	$6,975.00
3/7/2016	Garo H Armen	CEO	Buy	200,000	$4.03	$806,000.00
12/29/2015	Garo H. Armen	CEO	Sell	219,576	$4.59	$1,007,853.84
12/28/2015	Garo H. Armen	CEO	Sell	134,352	$4.60	$618,019.20
9/25/2015	Charles Evan Ballantyne	CFO	Buy	10,000	$5.05	$50,500.00
9/25/2015	Garo H Armen	CEO	Buy	100,000	$5.03	$503,000.00
4/29/2015	Shahzad Malik	Director	Sell	1,107,377	$7.11	$7,873,450.47
1/9/2015	Qvt Associates Gp Llc	Major Shareholder	Sell	2,343,630	$5.31	$12,444,675.30
1/23/2014	Karen Valentine	VP	Sell	2,850	$3.50	$9,975.00

(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Agenus (NASDAQ:AGEN)

Date	Headline
	US Nasdaq-quoted business moves into Cambridge (NASDAQ:AGEN) www.businessweekly.co.uk - September 23 at 3:48 PM
	Analysts Valuations For Two Stocks: Agenus Inc (NASDAQ:AGEN ... - The Voice Registrar (NASDAQ:AGEN) voiceregistrar.com - September 22 at 3:20 PM
	Interesting AGEN Put And Call Options For May 2017 (NASDAQ:AGEN) www.thestreet.com - September 21 at 4:01 PM
	Agenus Inc. (NASDAQ: AREX) stock reaches new 52-week high - BNB Daily (blog) (NASDAQ:AGEN) www.baseball-news-blog.com - September 20 at 3:22 PM
	Intraday Active Biotech Stocks News: Medivation, Inc. (NASDAQ:MDVN), Agenus Inc. (NASDAQ:AGEN) - The Voice Registrar (NASDAQ:AGEN) voiceregistrar.com - September 20 at 3:22 PM
	Agenus Inc. (NASDAQ:AGEN) topped earnings-per-share estimates 41% of the time - The Independent Republic (NASDAQ:AGEN) theindependentrepublic.com - September 20 at 9:10 AM
	Research Reports Initiation on Biotech Stocks -- Agenus, Nektar Therapeutics, GlobeImmune and Anthera Pharma - PR Newswire (press release) (NASDAQ:AGEN) www.prnewswire.com - September 20 at 9:10 AM
	Steady Stock Movements: Agenus Inc. (NASDAQ:AGEN), Sunrun Inc ... - Newburgh Press (NASDAQ:AGEN) newburghpress.com - September 19 at 4:16 PM
	News review of 2 biotech stocks: Agenus Inc. (NASDAQ:AGEN ... - The Voice Registrar (NASDAQ:AGEN) voiceregistrar.com - September 19 at 4:16 PM
	HC Stocks Assessment! Merrimack Pharmaceuticals Inc (MACK), Agenus Inc (NASDAQ:AGEN) - share market updates (press release) (NASDAQ:AGEN) sharemarketupdates.com - September 19 at 8:08 AM
	GSK shingles vaccine remains effective after four years: study (NASDAQ:AGEN) www.foxnews.com - September 16 at 3:22 PM
	Trading the Biotech News: Inotek Pharmaceuticals Corporation (NASDAQ:ITEK), Agenus Inc. (NASDAQ:AGEN) - The Voice Registrar (NASDAQ:AGEN) voiceregistrar.com - September 15 at 12:14 PM
	Today Agenus Inc Stock Rises - Chester Independent - Chester News (NASDAQ:AGEN) www.chesterindependent.com - September 15 at 12:14 PM
	2 Biotech Stocks News And Price Trends: Agenus Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:AGEN) voiceregistrar.com - September 12 at 3:22 PM
	Sep 6, 2016 (NASDAQ:AGEN) www.publicnow.com - September 12 at 3:22 PM
	Are These 3 Clinical-Stage Biotechs Still Buys After Soaring in August? (NASDAQ:AGEN) www.fool.com - September 11 at 8:07 AM
	Agenus Inc. (NASDAQ:AGEN) Sale Analysis - Newburg Press (NASDAQ:AGEN) newburghpress.com - September 8 at 11:54 AM
	Active biotech company shares in the news: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Agenus Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:AGEN) voiceregistrar.com - September 8 at 11:54 AM
	Active biotech company shares in the news: Clovis Oncology (CLVS), Agenus (NASDAQ:AGEN) - The Voice Registrar (NASDAQ:AGEN) voiceregistrar.com - September 7 at 8:30 PM
	Steering Attention Towards Earnings; Analysts Weigh in on Agenus Inc. (NASDAQ:AGEN) Stock - Frisco Fastball (NASDAQ:AGEN) friscofastball.com - September 7 at 3:22 PM
	Agenus to Present at the Rodman & Renshaw 18th Annual Global Investment Conference - PR Newswire (press release) (NASDAQ:AGEN) www.prnewswire.com - September 7 at 3:22 PM
	Trading the Biotech News: Cempra, Inc. (NASDAQ:CEMP), Agenus Inc. (NASDAQ:AGEN) - The Voice Registrar (NASDAQ:AGEN) voiceregistrar.com - September 6 at 3:21 PM
	Agenus Inc. (NASDAQ:AGEN) Near to Lift Curtain on September 2016 Earnings - The Voice Registrar (NASDAQ:AGEN) voiceregistrar.com - September 6 at 3:21 PM
	Agenus to Present at the Rodman & Renshaw 18th Annual Global Investment Conference (NASDAQ:AGEN) finance.yahoo.com - September 6 at 3:21 PM
	Biotech news that matter for investors: Sarepta Therapeutics, Inc. (NASDAQ:SRPT), Agenus Inc. (NASDAQ:AGEN) - The Voice Registrar (NASDAQ:AGEN) voiceregistrar.com - August 31 at 3:21 PM
	Time To Put On The Watch List? - Agenus Inc. (NASDAQ:AGEN), Galena Biopharma, Inc. (NASDAQ:GALE) - The Voice Registrar (NASDAQ:AGEN) voiceregistrar.com - August 30 at 3:21 PM
	Agenus Inc. (NASDAQ:AGEN) earnings expectations - The Independent Republic (NASDAQ:AGEN) theindependentrepublic.com - August 25 at 3:22 PM
	Top Earnings to Watch for: Agenus Inc. (NASDAQ:AGEN) - The Voice Registrar (NASDAQ:AGEN) voiceregistrar.com - August 25 at 3:22 PM
	Global vaccine adjuvants market research report - forecast to 2027 explored in latest research (NASDAQ:AGEN) www.whatech.com - August 24 at 11:39 AM
	ETF’s with exposure to Agenus, Inc. : August 23, 2016 (NASDAQ:AGEN) www.capitalcube.com - August 23 at 3:20 PM
	2 Under-the-Radar Cancer Stocks That are in the Bargain Bin Right Now (NASDAQ:AGEN) www.biospace.com - August 20 at 8:14 AM
	Sell-side is Weighing in on Agenus Inc. (NASDAQ:AGEN) Earnings - Post News (NASDAQ:AGEN) www.kentuckypostnews.com - August 19 at 11:45 AM
	2 Cancer Therapy Stocks That Are Ridiculously Cheap Right Now (NASDAQ:AGEN) www.fool.com - August 18 at 11:41 AM
	News review of 2 biotech stocks: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), Agenus Inc. (NASDAQ:AGEN) - The Voice Registrar (NASDAQ:AGEN) voiceregistrar.com - August 16 at 3:22 PM
	Vaccine Adjuvants Market worth 769.4 Million USD by 2021 (NASDAQ:AGEN) www.emailwire.com - August 15 at 10:37 AM
	Hot Biotech Stocks Recap: Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA), Agenus Inc. (NASDAQ:AGEN) - The Voice Registrar (NASDAQ:AGEN) voiceregistrar.com - August 12 at 3:32 PM
	AGENUS INC Financials (NASDAQ:AGEN) finance.yahoo.com - August 12 at 3:32 PM
	Why Agenus (AGEN) Stock Might be a Great Pick (NASDAQ:AGEN) finance.yahoo.com - August 12 at 11:55 AM
	Watch These 7 Huge Call Purchases In Friday Trade (NASDAQ:AGEN) feeds.benzinga.com - August 12 at 2:53 AM
	Research Report Initiation on Biotech Stocks -- Agenus, ProNAi Therapeutics, Vanda Pharma, and Genocea Biosciences (NASDAQ:AGEN) www.prnewswire.com - August 11 at 12:34 PM
	ETF’s with exposure to Agenus, Inc. : August 11, 2016 (NASDAQ:AGEN) www.capitalcube.com - August 11 at 12:34 PM
	Agenus, Inc. :AGEN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016 (NASDAQ:AGEN) www.capitalcube.com - August 10 at 3:41 PM
	Looking At Recent Analyst Ratings: Eclipse Resources Corp (NYSE:ECR), Agenus Inc (NASDAQ:AGEN) - Review Fortune (NASDAQ:AGEN) reviewfortune.com - August 9 at 3:59 PM
	Updated Analysts Rating Report: Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) , Agenus Inc. (NASDAQ:AGEN) - Street Updates (NASDAQ:AGEN) www.streetupdates.com - August 8 at 8:09 AM
	Jefferies Maintains Agenus Inc to Buy with Price Target $7.00 ... - Trade Calls (NASDAQ:AGEN) www.tradecalls.org - August 8 at 8:09 AM
	Traders Focused Stocks: Agenus Inc. (NASDAQ:AGEN) , Edwards ... - Street Updates (NASDAQ:AGEN) www.streetupdates.com - August 5 at 8:46 PM
	Agenus Inc. (AGEN) Jumps 9.03% on August 05 - Equities.com (NASDAQ:AGEN) www.equities.com - August 5 at 8:46 PM
	Agenus Inc (NASDAQ:AGEN): That’s How Our Members Are Already up 25% In 3-Week, Buy Call At $4.96 (NASDAQ:AGEN) www.marketnewscall.com - August 5 at 3:22 PM
	Discover the Global vaccine adjuvants market forecast to 2021 (NASDAQ:AGEN) www.whatech.com - August 5 at 11:45 AM
	Global Vaccine Adjuvants Sales Market Report to 2021: Brenntag Biosector, Seppic, CSL Limited, Agenus Inc (NASDAQ:AGEN) www.medgadget.com - August 5 at 11:45 AM

Social

Agenus (NASDAQ:AGEN) Chart for Saturday, September, 24, 2016